Greenwich LifeSciences, Inc. (NASDAQ:GLSI) shares are trading higher Monday after the company announced it extended its lock-up period to Sept. 30, 2026.

What To Know: Greenwich LifeSciences said its board extended the lock-up period for shares held by directors, officers and certain pre-IPO investors through Sept. 30, 2026. During the lock-up period, those shareholders are restricted from selling their common stock unless otherwise modified by the board.

The company said the lock-up extension is intended to align insiders with long-term investors and support its ongoing Phase III FLAMINGO-01 clinical trial. Greenwich added that the board retains the ability to modify the lock-up terms or implement a structured leak-out plan after the lock-up expires.

How To Buy Greenwich LifeSciences Stock

By now you’re likely curious about how to participate in the market for Greenwich LifeSciences – be it to purchase shares, or even attempt to bet against the company.

Buying shares is typically done through a brokerage account. You can find a list of possible trading platforms here. Many will allow you to buy “fractional shares,” which allows you to own portions of stock without buying an entire share.

If you’re looking to bet against a company, the process is more complex. You’ll need access to an options trading platform, or a broker who will allow you to “go short” a share of stock by lending you the shares to sell. The process of shorting a stock can be found at this resource. Otherwise, if your broker allows you to trade options, you can either buy a put option, or sell a call option at a strike price above where shares are currently trading – either way it allows you to profit off of the share price decline.

See Also: Target Shares Take A Breather Following Activist-Sparked Rally

GSLI Price Action: At the time of writing, Greenwich shares are trading 16.15% higher at $24.13, according to data from Benzinga Pro.

Image via Shutterstock